Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_assertion type Assertion NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_head.
- NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_assertion description "[A meta-analysis of neuroblastoma cases revealed that ALK mutations (49 of 709 cases) in relation to genomic subtype were most frequently observed in MYCN amplified tumours (8.9%), correlating with a poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_provenance.
- NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_assertion evidence source_evidence_literature NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_provenance.
- NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_assertion SIO_000772 22286764 NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_provenance.
- NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_assertion wasDerivedFrom befree-20140225 NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_provenance.
- NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_assertion wasGeneratedBy ECO_0000203 NP170598.RA8cIPq-oW-fXdXfh91tmKHvPpjR_7znznpeCdYBFTDm4130_provenance.